What is Colorescience?
Colorescience distinguishes itself in the competitive beauty market through its commitment to science-backed, mineral-based formulations. Specializing in clinically validated skincare and sun protection, the brand emphasizes cosmetically elegant finishes that appeal to both consumers and medical professionals. Its products are widely recommended by dermatologists, plastic surgeons, and aestheticians, highlighting the brand's efficacy and trust within the medical spa community. Colorescience employs a diversified omni-channel sales strategy, encompassing direct-to-consumer channels, e-commerce platforms, and the professional medical channel, ensuring broad market accessibility for its scientifically advanced offerings.
How much funding has Colorescience raised?
Colorescience has raised a total of $87.6M across 9 funding rounds:
Series A
$10M
Series B
$15M
Debt
$4M
Other Financing Round
$6.5M
Private Equity
$4.2M
Series C
$15M
Debt
$1M
Debt
$30M
Debt
$1.9M
Series A (2013): $10M with participation from Split Rock Partners and Montreux Equity Partners.
Series B (2014): $15M led by Longwood Fund
Debt (2016): $4M, investors not publicly disclosed
Other Financing Round (2016): $6.5M featuring Bridge Bank
Private Equity (2017): $4.2M, investors not publicly disclosed
Series C (2017): $15M with participation from Greenspring Global Partners, 1315 Capital, Montreux Equity Partners, and Healthcare Ventures
Debt (2020): $1M led by PPP
Debt (2020): $30M supported by K2 HealthVentures
Debt (2021): $1.9M featuring PPP
Key Investors in Colorescience
Longwood Fund
Longwood Fund is a venture capital firm that creates and invests in science-based companies focused on developing innovative solutions for significant medical challenges. The firm partners with world-class scientific co-founders to identify groundbreaking discoveries and actively collaborates in building companies, often taking leadership roles.
Greenspring Global Partners
Founded in 2000, Greenspring Associates is a venture capital investment firm that serves as a lifecycle partner for fund managers and entrepreneurs both on a primary and secondary basis across multiple stages, sectors and geographies.
1315 Capital
1315 Capital is a healthcare-focused investment firm that specializes in commercial-stage healthcare companies, including healthcare services, pharma/medtech products, outsourcing, and health & wellness.
What's next for Colorescience?
With a substantial enterprise-level funding context, Colorescience is strategically positioned for accelerated growth and market penetration. The recent capital infusion, though undisclosed, signals a strong endorsement of the company's trajectory and its potential to further innovate within the science-driven skincare and sun protection sector. Future initiatives are likely to focus on expanding its product portfolio, enhancing its direct-to-consumer engagement, and potentially exploring new international markets. The company's established reputation for efficacy and its strong ties to the medical professional community provide a robust foundation for sustained expansion and leadership in the premium skincare segment.
See full Colorescience company page
